Intas
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · India · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Corporate House Near Sola Bridge S. G. T...Phone Number
+91 7961577000Website
www.intaspharma.comRevenue
$2.3 BillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
6
6
1
2
2
1
About Intas
Intas was founded in 1976. This company provides the manufacturing and research of pharmaceuticals. Their headquarters are located in Ahmedabad, Gujarat, India.Explore more
Intas Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Intas your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Intas launches new products
Funding: Get notified immidiatlly once Intas has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Intas had a recent Job posting/layoffs
Intas, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Intas has recently received funding, and reach out quickly before it becomes old news!
Check out if Intas is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Intas
Earning: See what the market has to say on Intas recently announced quarterly report
Recommended Actions
Find VP level buyers at Intas
Find 2 more new buyers
Company Profile Activity
Activity Insights
Intas is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Intas is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Intas.
Intas financials insights
Gather financial insights about Intas, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Other Financing Round
$106.3M
Intas Tech Stack
A closer look at the technologies used by Intas
See more technologies
Most Recent Scoops
Person-Based
Hiring Plans
Intas has more open roles in Operations than it has had at any time in the past 12 months. Technologies mentioned include: SAP.
Hiring Plans
Hiring Plans
Intas has more open roles in Finance than it has had at any time in the past 12 months.
Hiring Plans
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Intas News & Media
Bio-Thera Solutions' Golimumab Biosimilars Receive FDA Approval as First Biosimilars to Simponi® and Simponi Aria®; Accord BioPharma to Commercialize IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi) in the United States
GUANGZHOU, China, May 18, 2026 /PRNewswire/ -- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and Accord BioPharma, Inc, the U.S. specialty division of Intas Pharmaceuticals, Ltd. ("Intas"),...Accord BioPharma's IMULDOSA® (ustekinumab-srlf) Now Preferred Under Cigna Healthcare Commercial Plans
Prefilled syringes (PFS) preferred on pharmacy benefit; vials preferred on medical benefit RALEIGH, N.C., April 20, 2026 /PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology and immunology therapies, announced...Bio-Thera Solutions Announces Further Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License Agreement in India
GUANGZHOU, China, March 23, 2026 /PRNewswire/ -- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today announced a further expansion of its partnership with Intas Pharmaceuticals for BAT2506, a...FDA Approves FILKRI™ (filgrastim-laha), Accord BioPharma's Biosimilar to NEUPOGEN® (filgrastim)
FILKRI completes Accord BioPharma's comprehensive granulocyte colony-stimulating factor (G-CSF) portfolio alongside UDENYCA® (pegfilgrastim-cbqv) RALEIGH, N.C., Feb. 17, 2026 /PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Intas
Sign Up For FreeTo access detailed company insights
Intas was founded in 1976. This company provides the manufacturing and research of pharmaceuticals. Their headquarters are located in Ahmedabad, Gujarat, India.... Read More
